Child-safety Containers/Devices and Compounding
Download in electronic PDF format for $75
Abstract: The U.S. Consumer Product Safety Commission has been around since it was created in 1972 through the Consumer Product Safety Act. Its purpose is to protect “against unreasonable risks of injuries associated with consumer products.” Manufactured drugs must meet the standards unless specifically exempted. Dispensing and compounding pharmacists must also meet the standards. Due to a smaller market size, compliant products to meet the U.S. Consumer Product Safety Commission’s standards to aid compounding pharmacists have been slow in coming. However, now there are numerous different products, some introduced recently, which make it easier for compounding pharmacists to comply with the standards. The new technologies are innovative and serve a great need.
Related Keywords:
Loyd V. Allen, Jr., PhD, RPh, U.S. Consumer Product Safety Commission, drug packaging, child-resistant container, Poison Prevention Packaging Act, poisoning
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 364-370
|
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety
Allen W Chris, Greeson Nicole MH, Mixon William
|
Nov/Dec 2020
Pg. 451-458
|
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 311-317
|
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention
Stein Michael F, Parsons Eric
|
Jul/Aug 2003
Pg. 272-275
|
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
How to Qualify Container Closure Systems for Intended Use, Part 1
Kim Amy A, Gehrmann Matthew R, McCaw James, McAndrew T Page
|
Nov/Dec 2019
Pg. 454-461
|
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
|
Nov/Dec 2015
Pg. 491-500
|
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 351
View Sample |
How to Qualify Container Closure Systems for Intended Use, Part 2: Choosing the Right Components for Container Closure Systems
Vaughn Stacey R, Radwick Allison
|
Jan/Feb 2020
Pg. 14-19
|
Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration
Greeson Nicole MH, Mixon William, Allan W Chris
|
Jul/Aug 2020
Pg. 270-276
|
A Review of Parenteral Admixtures Requiring Select Containers and Administration Sets
Rice Stephen P
|
Mar/Apr 2002
Pg. 120-122
|
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
|
Sep/Oct 2021
Pg. 358-362
|
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 487-488
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 92
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
|
Jul/Aug 2020
Pg. 287-295
|
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018
Pg. 387-398
|
Current Trends and Emerging Priorities in Compounded Preparations for Children
Parrish Richard H II
|
Sep/Oct 2018
Pg. 358-366
|
| Return to Top |
